Skip to main content
. 2020 Oct 27;10(4):1827–1832. doi: 10.3233/JPD-202101

Table 2.

The number (percentage) of PKG™ findings as reported by the clinician in the Follow-up and New Patient pathways

PKG™ Findings Follow-Up New Patient
(N = 88) (N = 78)
Bradykinesia 55 (63%) 56 (72%)
Dyskinesia 15 (17%) 3 (4%)
Sleep fragmentation* 46 (58% of 80) 32 (41%)
Daytime somnolence 16 (18%) 25 (32%)
Prevalent tremor** 16 (34% of 47) 29 (40% of 72)
Wearing off 40 (45%) 14 (18%)
Delayed “ON” 16 (18%) 0
No clear drug response 14 (16%) 7 (9%)

*Note: Overnight recording became available in November 2015; it is was not available for 8 patients in the FU pathway. **Tremor recording became available in August 2016; it was not available for 41 patients in the FU pathway and 6 patients in the NP pathway.